Coleman MF, McDonell SB, Eisenbeis LK, Devericks EN, et al. The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression. Breast Cancer Res 2025;27:186.
PMID: 41137072